Highlander Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $47.4K | Hold |
500
| – | – | 0.02% | 402 |
|
2023
Q4 | $44.6K | Hold |
500
| – | – | 0.02% | 408 |
|
2023
Q3 | $37K | Buy |
500
+200
| +67% | +$14.8K | 0.01% | 415 |
|
2023
Q2 | $25K | Hold |
300
| – | – | 0.01% | 399 |
|
2023
Q1 | $23K | Hold |
300
| – | – | 0.01% | 407 |
|
2022
Q4 | $25K | Hold |
300
| – | – | 0.01% | 368 |
|
2022
Q3 | $24K | Hold |
300
| – | – | 0.01% | 360 |
|
2022
Q2 | $22K | Hold |
300
| – | – | 0.01% | 391 |
|
2022
Q1 | $27K | Hold |
300
| – | – | 0.01% | 367 |
|
2021
Q4 | $34K | Hold |
300
| – | – | 0.02% | 341 |
|
2021
Q3 | $38K | Hold |
300
| – | – | 0.02% | 315 |
|
2021
Q2 | $41K | Hold |
300
| – | – | 0.02% | 318 |
|
2021
Q1 | $41K | Hold |
300
| – | – | 0.02% | 311 |
|
2020
Q4 | $42K | Hold |
300
| – | – | 0.02% | 309 |
|
2020
Q3 | $33K | Hold |
300
| – | – | 0.02% | 337 |
|
2020
Q2 | $34K | Hold |
300
| – | – | 0.02% | 331 |
|
2020
Q1 | $23K | Hold |
300
| – | – | 0.02% | 381 |
|
2019
Q4 | $29K | Hold |
300
| – | – | 0.02% | 375 |
|
2019
Q3 | $23K | Hold |
300
| – | – | 0.01% | 409 |
|
2019
Q2 | $26K | Hold |
300
| – | – | 0.02% | 417 |
|
2019
Q1 | $27K | Hold |
300
| – | – | 0.02% | 411 |
|
2018
Q4 | $22K | Hold |
300
| – | – | 0.01% | 429 |
|
2018
Q3 | $29K | Hold |
300
| – | – | 0.02% | 432 |
|
2018
Q2 | $29K | Hold |
300
| – | – | 0.02% | 433 |
|
2018
Q1 | $27K | Hold |
300
| – | – | 0.02% | 439 |
|
2017
Q4 | $25K | Hold |
300
| – | – | 0.02% | 459 |
|
2017
Q3 | $26K | Hold |
300
| – | – | 0.02% | 454 |
|
2017
Q2 | $23K | Hold |
300
| – | – | 0.02% | 487 |
|
2017
Q1 | $21K | Buy |
+300
| New | +$21K | 0.02% | 501 |
|